Cleveland HeartLab Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 83

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $94M

Cleveland HeartLab General Information

Description

Operator of a clinical reference laboratory specializing in cardiovascular disease prevention intended to improve the early identification of those with cardiovascular disease (CVD) risk. The company focuses on novel molecular bio-marker technologies and the creation of proprietary diagnostic tests for managing and reducing inflammation. It offers clinical laboratory services, such as cardiovascular disease (CVD) inflammatory panel, advanced CVD risk profile, lipid panel, and future test services.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 6701 Carnegie Avenue
  • Suite 500
  • Cleveland, OH 44103
  • United States
+1 (866)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Parent Company
Corporate Office
  • 6701 Carnegie Avenue
  • Suite 500
  • Cleveland, OH 44103
  • United States
+1 (866)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cleveland HeartLab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 01-Dec-2017 $94M Completed Generating Revenue
7. Later Stage VC (Series D) 01-Apr-2016 Completed Generating Revenue
6. Later Stage VC (Series C) 08-Jul-2014 Completed Generating Revenue
5. Early Stage VC (Series B1) 17-Oct-2012 Completed Generating Revenue
4. Early Stage VC (Series B) 23-Aug-2011 Completed Generating Revenue
3. Early Stage VC 02-Mar-2010 Completed Startup
2. Early Stage VC 01-Dec-2009 $2.5M $7M Completed Startup
1. Early Stage VC (Series A) $4.5M $4.5M Completed Startup
To view Cleveland HeartLab’s complete valuation and funding history, request access »

Cleveland HeartLab Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B1
Series B 19,976,689 $0.000100 6% $0.92 $0.92 1x $0.92 28.79%
Series A 12,569,356 $0.000100 6% $0.92 $0.92 1x $0.92 18.12%
To view Cleveland HeartLab’s complete cap table history, request access »

Cleveland HeartLab Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical reference laboratory specializing in cardiovascular disease prevention intended to improve the ea
Laboratory Services (Healthcare)
Cleveland, OH
83 As of 2023

Salt Lake City, UT
 

Lee's Summit, MO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cleveland HeartLab Competitors (29)

One of Cleveland HeartLab’s 29 competitors is ARUP Laboratories, a Corporation company based in Salt Lake City, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ARUP Laboratories Corporation Salt Lake City, UT
Bioquintex Laboratories Private Equity-Backed Lee's Summit, MO
SpectraCell Laboratories Formerly PE-Backed Houston, TX
Dynacare Healthcare Services Formerly PE-Backed Brampton, Canada
NMS Labs Corporation Horsham, PA
You’re viewing 5 of 29 competitors. Get the full list »

Cleveland HeartLab Patents

Cleveland HeartLab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11237167-B2 Lp-pla2 assays and composition with detergent Active 24-Jan-2017
US-20180209977-A1 Lp-pla2 assays and composition with detergent Active 24-Jan-2017
US-20220155302-A1 Lp-pla2 assays and composition with detergent Pending 24-Jan-2017
JP-2022025100-A Biomarker panel detection of hdl-related proteins Active 21-Jul-2016
EP-3488241-A4 Hdl-associated protein biomarker panel detection Active 21-Jul-2016 G01N33/92
To view Cleveland HeartLab’s complete patent history, request access »

Cleveland HeartLab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cleveland HeartLab Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abundance Partners Venture Capital Minority
Advantage Capital PE/Buyout Minority
Bratenahl Capital Partners Family Office Minority
Excel Venture Management Venture Capital Minority
Frantz Medical Ventures Corporate Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Cleveland HeartLab Investments & Acquisitions (2)

Cleveland HeartLab’s most recent deal was a Merger/Acquisition with True Health Diagnostics for . The deal was made on 01-Oct-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
True Health Diagnostics 01-Oct-2019 Merger/Acquisition Laboratory Services (Healthcare)
Cleveland HeartLab (MIRISK Heart Attack Risk Assessment Tool) 07-Jan-2015 Corporate Asset Purchase Buildings and Property
To view Cleveland HeartLab’s complete investments and acquisitions history, request access »

Cleveland HeartLab FAQs

  • When was Cleveland HeartLab founded?

    Cleveland HeartLab was founded in 2009.

  • Where is Cleveland HeartLab headquartered?

    Cleveland HeartLab is headquartered in Cleveland, OH.

  • What is the size of Cleveland HeartLab?

    Cleveland HeartLab has 83 total employees.

  • What industry is Cleveland HeartLab in?

    Cleveland HeartLab’s primary industry is Laboratory Services (Healthcare).

  • Is Cleveland HeartLab a private or public company?

    Cleveland HeartLab is a Private company.

  • What is the current valuation of Cleveland HeartLab?

    The current valuation of Cleveland HeartLab is .

  • What is Cleveland HeartLab’s current revenue?

    The current revenue for Cleveland HeartLab is .

  • How much funding has Cleveland HeartLab raised over time?

    Cleveland HeartLab has raised $56.5M.

  • Who are Cleveland HeartLab’s investors?

    Abundance Partners, Advantage Capital, Bratenahl Capital Partners, Excel Venture Management, and Frantz Medical Ventures are 5 of 12 investors who have invested in Cleveland HeartLab.

  • Who are Cleveland HeartLab’s competitors?

    ARUP Laboratories, Bioquintex Laboratories, SpectraCell Laboratories, Dynacare Healthcare Services, and NMS Labs are some of the 29 competitors of Cleveland HeartLab.

  • When was Cleveland HeartLab acquired?

    Cleveland HeartLab was acquired on 01-Dec-2017.

  • Who acquired Cleveland HeartLab?

    Cleveland HeartLab was acquired by Quest Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »